AU2003238175A1 - Treatment of serious infections and septic shock - Google Patents

Treatment of serious infections and septic shock

Info

Publication number
AU2003238175A1
AU2003238175A1 AU2003238175A AU2003238175A AU2003238175A1 AU 2003238175 A1 AU2003238175 A1 AU 2003238175A1 AU 2003238175 A AU2003238175 A AU 2003238175A AU 2003238175 A AU2003238175 A AU 2003238175A AU 2003238175 A1 AU2003238175 A1 AU 2003238175A1
Authority
AU
Australia
Prior art keywords
treatment
septic shock
serious infections
infections
serious
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003238175A
Inventor
Nina Brunner
Christoph Gerdes
Harald Labischinski
Christoph Ladel
Ben Newton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer Healthcare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG
Publication of AU2003238175A1 publication Critical patent/AU2003238175A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
AU2003238175A 2002-06-13 2003-05-30 Treatment of serious infections and septic shock Abandoned AU2003238175A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10226216.0 2002-06-13
DE10226216A DE10226216A1 (en) 2002-06-13 2002-06-13 Treatment of severe infections and septic shock
PCT/EP2003/005694 WO2003105883A1 (en) 2002-06-13 2003-05-30 Treatment of serious infections and septic shock

Publications (1)

Publication Number Publication Date
AU2003238175A1 true AU2003238175A1 (en) 2003-12-31

Family

ID=29594458

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003238175A Abandoned AU2003238175A1 (en) 2002-06-13 2003-05-30 Treatment of serious infections and septic shock

Country Status (5)

Country Link
EP (1) EP1523324A1 (en)
AU (1) AU2003238175A1 (en)
CA (1) CA2489244A1 (en)
DE (1) DE10226216A1 (en)
WO (1) WO2003105883A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7119070B2 (en) 2002-04-30 2006-10-10 The Regents Of The University Of California Antimicrobial theta defensins, analogs thereof, and methods of use
EP1850861A1 (en) * 2005-02-08 2007-11-07 Novozymes A/S Systemic treatment of infections with defensins
RU2652605C2 (en) * 2011-06-02 2018-04-27 Зе Реджентс Оф Зе Юниверсити Оф Калифорния Blocking of inflammatory proteases by theta-defensins
US20170035845A1 (en) * 2015-08-07 2017-02-09 The Regents Of The University Of California Compositions and Methods for Inhibiting Pro-Inflammatory Cytokine Gene Expression
CN114072415A (en) 2019-06-26 2022-02-18 迈克尔·E·塞尔斯特德 Compositions and methods for treating fungal infections

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6335318B1 (en) * 1999-05-10 2002-01-01 The Regents Of The University Of California Antimicrobial theta defensins and methods of using same

Also Published As

Publication number Publication date
EP1523324A1 (en) 2005-04-20
WO2003105883A1 (en) 2003-12-24
CA2489244A1 (en) 2003-12-24
DE10226216A1 (en) 2003-12-24

Similar Documents

Publication Publication Date Title
AU2003290548A1 (en) Prevention and treatment of synucleinopathic disease
AU2002257936A1 (en) Methods of well treatment
AU2003901008A0 (en) Composition for the treatment and prevention of bacterial infections
AU2003217159A1 (en) Compositions and methods for the treatment of wastewater and other waste
AU2002356868A1 (en) Methods for the prevention or treatment of bacterial and fungal infections
EP1531828A4 (en) Methods of treating bacterial infections and diseases associated therewith
AU2003279526A1 (en) Identifying and treating vaginal infections
AU2002364964A1 (en) Galliumcomplexes of 3-hydroxy-4-pyrones to treat mycobacterial infections
AU2003220097A1 (en) Synergistic enhancement of cognitive ability
AU2003902354A0 (en) Treatment of haemorrhagic shock
AU2003296963A1 (en) Methods and compositions for treating and preventing ear infections
AU2003291886A1 (en) Thiophenederivatives for the treatment of flavivirus infections
AU2003268923A1 (en) Treatment of aml
AU2003238175A1 (en) Treatment of serious infections and septic shock
AU2003301012A1 (en) Use of beta-defensins for treating hiv infections
AU2001245414A1 (en) Treatment of allergies
AU2003221005A1 (en) Method of wastewater treatment
AU2003213898A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2002952129A0 (en) Treatment of hypersensitivity conditions
AU2002334761A1 (en) Methods of treating drug-resistant bacterial infections
AU2002241162A1 (en) Intimins in the prevention or treatment of infections:ii
AU2003290506A1 (en) Methods and devices for treating severe peripheral bacterial infections
AU2001281465A1 (en) Treatment of rosacea
AU2002361488A1 (en) Field and background of the invention
AU1392601A (en) Prevention and treatment of biomaterial-associated infections

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase